AMS Quote, Financials, Valuation and Earnings

biote Corp. has a net margin of -4.59% compared to American Shared Hospital Services's net margin of 19.22%. American Shared Hospital Services's return on equity of -12.09% beat biote Corp.'s return on equity of --.

American Shared Hospital Services has a consensus price target of $4.50, signalling upside risk potential of 116.35%. On the other hand biote Corp. has an analysts' consensus of $4.51 which suggests that it could grow by 62.3%. Given that American Shared Hospital Services has higher upside potential than biote Corp., analysts believe American Shared Hospital Services is more attractive than biote Corp..

American Shared Hospital Services has a beta of 0.122, which suggesting that the stock is 87.793% less volatile than S&P 500. In comparison biote Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. biote Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Shared Hospital Services pays -- of its earnings as a dividend. biote Corp. pays out -- of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $7.2M, which are smaller than biote Corp. quarterly revenues of $48M. American Shared Hospital Services's net income of -$329K is lower than biote Corp.'s net income of $9.2M. Notably, American Shared Hospital Services's price-to-earnings ratio is 11.73x while biote Corp.'s PE ratio is 3.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.47x versus 0.51x for biote Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Cryo-Cell International, Inc. has a net margin of -4.59% compared to American Shared Hospital Services's net margin of 9.58%. American Shared Hospital Services's return on equity of -12.09% beat Cryo-Cell International, Inc.'s return on equity of --.

American Shared Hospital Services has a consensus price target of $4.50, signalling upside risk potential of 116.35%. On the other hand Cryo-Cell International, Inc. has an analysts' consensus of $8.50 which suggests that it could grow by 129.73%. Given that Cryo-Cell International, Inc. has higher upside potential than American Shared Hospital Services, analysts believe Cryo-Cell International, Inc. is more attractive than American Shared Hospital Services.

American Shared Hospital Services has a beta of 0.122, which suggesting that the stock is 87.793% less volatile than S&P 500. In comparison Cryo-Cell International, Inc. has a beta of 0.669, suggesting its less volatile than the S&P 500 by 33.089%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cryo-Cell International, Inc. offers a yield of 17.57% to investors and pays a quarterly dividend of $0.15 per share. American Shared Hospital Services pays -- of its earnings as a dividend. Cryo-Cell International, Inc. pays out 510.2% of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $7.2M, which are smaller than Cryo-Cell International, Inc. quarterly revenues of $7.8M. American Shared Hospital Services's net income of -$329K is lower than Cryo-Cell International, Inc.'s net income of $749.4K. Notably, American Shared Hospital Services's price-to-earnings ratio is 11.73x while Cryo-Cell International, Inc.'s PE ratio is 498.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.47x versus 0.95x for Cryo-Cell International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

P3 Health Partners, Inc. has a net margin of -4.59% compared to American Shared Hospital Services's net margin of -20.12%. American Shared Hospital Services's return on equity of -12.09% beat P3 Health Partners, Inc.'s return on equity of -223.63%.

American Shared Hospital Services has a consensus price target of $4.50, signalling upside risk potential of 116.35%. On the other hand P3 Health Partners, Inc. has an analysts' consensus of $10.25 which suggests that it could grow by 148.79%. Given that P3 Health Partners, Inc. has higher upside potential than American Shared Hospital Services, analysts believe P3 Health Partners, Inc. is more attractive than American Shared Hospital Services.

American Shared Hospital Services has a beta of 0.122, which suggesting that the stock is 87.793% less volatile than S&P 500. In comparison P3 Health Partners, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. P3 Health Partners, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Shared Hospital Services pays -- of its earnings as a dividend. P3 Health Partners, Inc. pays out -- of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $7.2M, which are smaller than P3 Health Partners, Inc. quarterly revenues of $345.3M. American Shared Hospital Services's net income of -$329K is higher than P3 Health Partners, Inc.'s net income of -$69.5M. Notably, American Shared Hospital Services's price-to-earnings ratio is 11.73x while P3 Health Partners, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.47x versus 0.01x for P3 Health Partners, Inc.. Usually stocks with elevated PS ratios are considered overvalued.